2,3-dinor-thromboxane b2 and leukotriene e4

2,3-dinor-thromboxane b2 has been researched along with leukotriene e4 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bizzi, B; Castellana, MA; Ciabattoni, G; Landolfi, R; Patrignani, P; Patrono, C; Pogliani, E1
Barnes, PJ; Carty, TJ; Chung, KF; Eskra, JD; O'Connor, BJ; Uden, S1
Fauler, J; Frölich, JC; Thon, A; Tsikas, D; von der Hardt, H1

Trials

1 trial(s) available for 2,3-dinor-thromboxane b2 and leukotriene e4

ArticleYear
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
    American journal of respiratory and critical care medicine, 1994, Volume: 150, Issue:1

    Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Bronchoconstriction; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Eicosanoids; Humans; Imidazoles; Leukocyte Count; Leukotriene E4; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Thromboxane B2

1994

Other Studies

2 other study(ies) available for 2,3-dinor-thromboxane b2 and leukotriene e4

ArticleYear
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
    Blood, 1992, Oct-15, Volume: 80, Issue:8

    Topics: Adult; Aged; Aspirin; Blood Platelets; Female; Humans; Kinetics; Leukotriene E4; Male; Middle Aged; Platelet Activation; Polycythemia Vera; SRS-A; Thromboxane A2; Thromboxane B2

1992
Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis.
    Arthritis and rheumatism, 1994, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Arthritis, Juvenile; Aspirin; Child; Gas Chromatography-Mass Spectrometry; Humans; Leukotriene C4; Leukotriene D4; Leukotriene E4; Thromboxane B2

1994